Eli Lilly and Company will invest US$470 million for the construction of a new state-of-the-art pharmaceutical manufacturing facility in North Carolina's Research Triangle Park.
The new manufacturing site will manufacture parenteral/injectable products and delivery devices.
The new facility will allow Eli Lilly to expand its capacity to make the company's medicines that are helping people will serious illnesses and help the company prepare for new medicines coming from its robust pipeline in the future.
The North Carolina General Assembly, the North Carolina Community College System, the North Carolina Biotechnology Center, Durham County, the Greater Durham Chamber of Commerce and Duke Energy have partnered with N.C. Commerce and the Economic Development Partnership of N.C. on this project.
|Eli Lilly and Company